Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial.
Saved in:
| Title: | Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. |
|---|---|
| Authors: | Keystone EC (AUTHOR), Kavanaugh AF (AUTHOR), Sharp JT (AUTHOR), Tannenbaum H (AUTHOR), Hua Y (AUTHOR), Teoh LS (AUTHOR), Fischkoff SA (AUTHOR), Chartash EK (AUTHOR) |
| Source: | Arthritis & Rheumatism. May2004, Vol. 50 Issue 5, p1400-1411. 12p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
